Jillian Pintye1,2, Alison L Drake1, John Kinuthia3, Jennifer A Unger4, Daniel Matemo3, Renee A Heffron1,5, Ruanne V Barnabas1,5,6, Pamela Kohler1,7, R Scott McClelland1,5,6,8, Grace John-Stewart1,5,6,9. 1. Department of Global Health, University of Washington, Seattle, USA. 2. Family and Child Nursing, University of Washington, Seattle, USA. 3. Department of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya. 4. Departments of Global Health and Obstetrics and Gynecology, University of Washington, Box 359909, Seattle, WA, USA. 5. Department of Epidemiology, University of Washington, Seattle, WA, USA. 6. Department of Medicine, University of Washington, Seattle, Washington, USA. 7. Psychosocial and Community Health, University of Washington, Seattle, USA. 8. University of Nairobi Institute of Tropical and Infectious Diseases, University of Nairobi, Kenya. 9. Department of Pediatrics, University of Washington, Seattle, USA.
Abstract
Background: A human immunodeficiency virus (HIV) risk assessment tool for pregnant women could identify women who would most benefit from preexposure prophylaxis (PrEP) while minimizing unnecessary PrEP exposure. Methods: Data from a prospective study of incident HIV among pregnant/postpartum women in Kenya were randomly divided into derivation (n = 654) and validation (n = 650) cohorts. A risk score was derived using multivariate Cox proportional hazards models and standard clinical prediction rules. Ability of the tool to predict maternal HIV acquisition was assessed using the area under the curve (AUC) and Brier score. Results: The final risk score included the following predictors: having a male partner with unknown HIV status, number of lifetime sexual partners, syphilis, bacterial vaginosis (BV), and vaginal candidiasis. In the derivation cohort, AUC was 0.84 (95% confidence interval [CI], .72-.95) and each point increment in score was associated with a 52% (hazard ratio [HR], 1.52 [95% CI, 1.32-1.76]; P < .001) increase in HIV risk; the Brier score was 0.11. In the validation cohort, the score had similar AUC, Brier score, and estimated HRs. A simplified score that excluded BV and candidiasis yielded an AUC of 0.76 (95% CI, .67-.85); HIV incidence was higher among women with risk scores >6 than with scores ≤6 (7.3 vs 1.1 per 100 person-years, respectively; P < .001). Women with simplified scores >6 accounted for 16% of the population but 56% of HIV acquisitions. Conclusions: A combination of indicators routinely assessed in antenatal clinics was predictive of HIV risk and could be used to prioritize pregnant women for PrEP.
Background: A human immunodeficiency virus (HIV) risk assessment tool for pregnant women could identify women who would most benefit from preexposure prophylaxis (PrEP) while minimizing unnecessary PrEP exposure. Methods: Data from a prospective study of incident HIV among pregnant/postpartum women in Kenya were randomly divided into derivation (n = 654) and validation (n = 650) cohorts. A risk score was derived using multivariate Cox proportional hazards models and standard clinical prediction rules. Ability of the tool to predict maternal HIV acquisition was assessed using the area under the curve (AUC) and Brier score. Results: The final risk score included the following predictors: having a male partner with unknown HIV status, number of lifetime sexual partners, syphilis, bacterial vaginosis (BV), and vaginal candidiasis. In the derivation cohort, AUC was 0.84 (95% confidence interval [CI], .72-.95) and each point increment in score was associated with a 52% (hazard ratio [HR], 1.52 [95% CI, 1.32-1.76]; P < .001) increase in HIV risk; the Brier score was 0.11. In the validation cohort, the score had similar AUC, Brier score, and estimated HRs. A simplified score that excluded BV and candidiasis yielded an AUC of 0.76 (95% CI, .67-.85); HIV incidence was higher among women with risk scores >6 than with scores ≤6 (7.3 vs 1.1 per 100 person-years, respectively; P < .001). Women with simplified scores >6 accounted for 16% of the population but 56% of HIV acquisitions. Conclusions: A combination of indicators routinely assessed in antenatal clinics was predictive of HIV risk and could be used to prioritize pregnant women for PrEP.
Authors: Jean H Humphrey; John W Hargrove; Lucie C Malaba; Peter J Iliff; Lawrence H Moulton; Kuda Mutasa; Partson Zvandasara; Kusum J Nathoo; Faith Mzengeza; Henry Chidawanyika; Lynn S Zijenah; Brian J Ward Journal: AIDS Date: 2006-06-26 Impact factor: 4.177
Authors: Leigh F Johnson; Kathryn Stinson; Marie-Louise Newell; Ruth M Bland; Harry Moultrie; Mary-Ann Davies; Thomas M Rehle; Rob E Dorrington; Gayle G Sherman Journal: J Acquir Immune Defic Syndr Date: 2012-04-01 Impact factor: 3.731
Authors: V Leroy; P Van de Perre; P Lepage; J Saba; F Nsengumuremyi; A Simonon; E Karita; P Msellati; R Salamon; F Dabis Journal: AIDS Date: 1994-07 Impact factor: 4.177
Authors: Roger Ying; Monisha Sharma; Renee Heffron; Connie L Celum; Jared M Baeten; Elly Katabira; Nulu Bulya; Ruanne V Barnabas Journal: J Int AIDS Soc Date: 2015-07-20 Impact factor: 5.396
Authors: Jillian Pintye; Alison L Drake; Emily Begnel; John Kinuthia; Felix Abuna; Harison Lagat; Julia Dettinger; Anjuli D Wagner; Harsha Thirumurthy; Kenneth Mugwanya; Jared M Baeten; Grace John-Stewart Journal: AIDS Date: 2019-07-01 Impact factor: 4.177
Authors: Elizabeth Wahome; Alexander N Thiong'o; Grace Mwashigadi; Oscar Chirro; Khamisi Mohamed; Evans Gichuru; John Mwambi; Matt A Price; Susan M Graham; Eduard J Sanders Journal: AIDS Behav Date: 2018-07
Authors: Jillian Pintye; Dvora L Joseph Davey; Anjuli D Wagner; Grace John-Stewart; Rachel Baggaley; Linda-Gail Bekker; Connie Celum; Benjamin H Chi; Thomas J Coates; Allison K Groves; Jessica E Haberer; Renee Heffron; John Kinuthia; Lynn T Matthews; James A McIntyre; Dhayendre Moodley; Lynne M Mofenson; Nelly Mugo; Andrew Mujugira; Landon Myer; Steven Shoptaw; Lynda Stranix-Chibanda; Jared M Baeten Journal: Lancet HIV Date: 2020-08 Impact factor: 12.767
Authors: Joan T Price; Nora E Rosenberg; Dhrutika Vansia; Twambilile Phanga; Nivedita L Bhushan; Bertha Maseko; Savvy K Brar; Mina C Hosseinipour; Jennifer H Tang; Linda-Gail Bekker; Audrey Pettifor Journal: J Acquir Immune Defic Syndr Date: 2018-01-01 Impact factor: 3.731